KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Operating Leases: 2021-2024

Historic Operating Leases for BioNTech SE (BNTX) over the last 4 years, with Dec 2024 value amounting to $271.6 million.

  • BioNTech SE's Operating Leases rose 16.50% to $271.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $271.6 million, marking a year-over-year increase of 16.50%. This contributed to the annual value of $271.6 million for FY2024, which is 16.50% up from last year.
  • Per BioNTech SE's latest filing, its Operating Leases stood at $271.6 million for FY2024, which was up 16.50% from $233.2 million recorded in FY2023.
  • BioNTech SE's 5-year Operating Leases high stood at $271.6 million for FY2024, and its period low was $207.7 million during FY2021.
  • Over the past 3 years, BioNTech SE's median Operating Leases value was $233.2 million (recorded in 2023), while the average stood at $239.7 million.
  • Data for BioNTech SE's Operating Leases shows a peak YoY rose of 16.50% (in 2024) over the last 5 years.
  • BioNTech SE's Operating Leases (Yearly) stood at $207.7 million in 2021, then climbed by 3.18% to $214.4 million in 2022, then rose by 8.77% to $233.2 million in 2023, then rose by 16.50% to $271.6 million in 2024.